Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OPGRY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2022135332A1 1-11
|
|||||
| Synonyms |
WO2022135332A1
Click to Show/Hide
|
|||||
| Organization |
Duality Biologics
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Rheumatoid arthritis [ICD11:FA20]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.77
|
|||||
| Structure |
|
|||||
| Antibody Name |
Adalimumab
|
Antibody Info | ||||
| Antigen Name |
Tumor necrosis factor (TNF)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
WO2022135332A1_1-11 linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.